Afatinib Dimaleate 40 mg
Price range: $2,212.00 through $6,300.00
Description
Afatinib dimaleate is a medication primarily used in the treatment of metastatic non-small cell lung cancer (NSCLC) that harbors specific genetic mutations known as EGFR (epidermal growth factor receptor) mutations. It belongs to a class of drugs called tyrosine kinase inhibitors, which work by blocking the activity of certain proteins involved in cancer cell growth and spread. Afatinib is specifically indicated for patients with NSCLC whose tumors have EGFR mutations. It is typically taken orally in tablet form.
| Active Ingredient (Generic Name): | Afatinib Dimaleate |
| Manufacturer: | Boehringer Ingelheim India Pvt.Ltd |
| Packaging: | 7 tablets in 1 strip |
| Strength: | 40 mg |
| Delivery Time: | 6 To 15 days |
| SKU: | Afatinib Dimaleate 40 mg |
Additional information
| Quantity Value | 28 Tablet/s, 56 Tablet/s, 84 Tablet/s |
|---|
Be the first to review “Afatinib Dimaleate 40 mg”
You must be logged in to post a review.
Related products
-
Lenalidomide 5 mg
Price range: $90.00 through $252.00 Select options This product has multiple variants. The options may be chosen on the product page -
Afatinib Dimaleate 50 mg
Price range: $2,268.00 through $6,468.00 Select options This product has multiple variants. The options may be chosen on the product page -
Mercaptopurine 50 mg
Price range: $120.00 through $216.00 Select options This product has multiple variants. The options may be chosen on the product page -
Afatinib 30 mg
Price range: $136.00 through $391.00 Select options This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.